NO872675L - Middel for hemning av avstoetning av transplanterte organer - Google Patents

Middel for hemning av avstoetning av transplanterte organer

Info

Publication number
NO872675L
NO872675L NO872675A NO872675A NO872675L NO 872675 L NO872675 L NO 872675L NO 872675 A NO872675 A NO 872675A NO 872675 A NO872675 A NO 872675A NO 872675 L NO872675 L NO 872675L
Authority
NO
Norway
Prior art keywords
heparin
disposal
inhibiting
humans
transplanted organs
Prior art date
Application number
NO872675A
Other languages
English (en)
Other versions
NO872675D0 (no
Inventor
Irun Cohen
Israel Vlodavsky
Amiram Eldor
Yaakov Naparstek
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO872675D0 publication Critical patent/NO872675D0/no
Publication of NO872675L publication Critical patent/NO872675L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Soil Working Implements (AREA)
  • Paper (AREA)
  • Fertilizers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO872675A 1986-06-26 1987-06-25 Middel for hemning av avstoetning av transplanterte organer NO872675L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL79254A IL79254A0 (en) 1986-06-26 1986-06-26 Compositions for preventing graft rejection

Publications (2)

Publication Number Publication Date
NO872675D0 NO872675D0 (no) 1987-06-25
NO872675L true NO872675L (no) 1987-12-28

Family

ID=11056896

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872675A NO872675L (no) 1986-06-26 1987-06-25 Middel for hemning av avstoetning av transplanterte organer

Country Status (10)

Country Link
EP (1) EP0251134B1 (no)
JP (1) JP2527749B2 (no)
AT (1) ATE82502T1 (no)
AU (1) AU608228B2 (no)
DE (1) DE3782686T2 (no)
DK (1) DK169422B1 (no)
ES (1) ES2052514T3 (no)
GR (1) GR3006814T3 (no)
IL (1) IL79254A0 (no)
NO (1) NO872675L (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85145A (en) * 1987-01-23 1994-08-26 Univ Australian Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
US5541166A (en) * 1987-01-23 1996-07-30 The Australian National University Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
GB8808810D0 (en) * 1988-04-14 1988-05-18 Biopharm Clinical Research Ltd Heparin-containing formulations
IL86753A0 (en) * 1988-06-15 1988-11-30 Hadassah Med Org Pharmaceutical compositions for treatment of lupus
DE3821271A1 (de) * 1988-06-23 1989-12-28 Solco Basel Ag Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
IL88554A0 (en) * 1988-12-01 1989-07-31 Hadassah Med Org Compositions containing a compound binding to a heparin receptor
US5158940A (en) * 1990-02-14 1992-10-27 The United States Government As Represented By The Secretary, Dhhs Use of suramin to treat rheumatologic diseases
ATE330620T1 (de) 1997-07-14 2006-07-15 Takashi Muramatsu Verwendung von midkin oder von anti-midkin antikörper
WO2003022291A1 (en) 2001-09-12 2003-03-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
AU2001234730A1 (en) 2000-02-01 2001-08-14 Beth Israel Deaconess Medical Center Method for inhibiting complement activation
CN1197587C (zh) * 2000-06-09 2005-04-20 中国科学院上海细胞生物学研究所 N－位脱硫酸肝素在预防和治疗炎症中的应用
EP1748781B1 (en) 2004-05-27 2012-12-19 Baxter International Inc. Methods for treating bleeding disorders using sulfated polysaccharides
EP2326334A2 (en) 2008-08-22 2011-06-01 Baxter Healthcare SA Methods for treating bleeding disorders
JP6393453B2 (ja) 2010-01-14 2018-09-19 バクスアルタ ゲーエムベーハー 出血性障害を治療するための方法及び組成物
DK2734213T3 (en) 2011-07-19 2018-08-13 Baxalta GmbH RESORPTION PROMOTERS ADDITIVES TO IMPROVE ORAL FORMULATION OF NON-ANTI-COATING SULPHATE POLYSACCHARIDS
ES2737025T3 (es) 2012-08-14 2020-01-09 Baxalta GmbH Métodos y sistemas para el cribado de composiciones que comprenden polisacáridos sulfados no anticoagulantes
WO2014158321A1 (en) 2013-03-12 2014-10-02 Baxter International Inc. Resorption enhancers as additives to improve the oral formulation of low molecular weight heparins
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate
ES2774102T3 (es) * 2015-06-11 2020-07-16 Univ Maastricht Procedimiento de prevención de fallos de trasplante en un huésped

Also Published As

Publication number Publication date
EP0251134A3 (en) 1989-05-03
NO872675D0 (no) 1987-06-25
EP0251134B1 (en) 1992-11-19
IL79254A0 (en) 1986-09-30
DE3782686D1 (de) 1992-12-24
GR3006814T3 (no) 1993-06-30
AU7470687A (en) 1988-01-07
DK331287D0 (da) 1987-06-26
ATE82502T1 (de) 1992-12-15
AU608228B2 (en) 1991-03-28
ES2052514T3 (es) 1994-07-16
JP2527749B2 (ja) 1996-08-28
DE3782686T2 (de) 1993-06-09
DK331287A (da) 1987-12-27
EP0251134A2 (en) 1988-01-07
DK169422B1 (da) 1994-10-31
JPS6388127A (ja) 1988-04-19

Similar Documents

Publication Publication Date Title
NO872675D0 (no) Middel for hemning av avstoetning av transplanterte organer
EP0184040A3 (en) Method and system for removing immunosuppressive components from the blood of mammals
ATE190496T1 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
ES2137225T3 (es) Eliminacion de anticuerpos de composiciones de derivados sanguineos reteniendo los factores de coagulacion.
ATE10340T1 (de) Stabilisierung der aktivitaet des faktors viii im blutplasma.
MX9101869A (es) Ciclosporinas, composicion farmaceutica que las contiene y procedimiento para la produccion de las mismas
OA07116A (fr) Esters aromatiques hétérocycliques de stéroïdes, leur préparation et compositions pharmaceutiques les contenant.
PT937048E (pt) Derivados heterociclicos que inibem factor xa
ES2032316T3 (es) Procedimiento para la esterilizacion de plasma o fracciones de plasma.
ATE76294T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
ES2082850T3 (es) Inmunoglobulinas preparadas geneticamente.
ATE135215T1 (de) Verwendung von rapamycin, dessen derivaten und prodrugs zur herstellung eines arzneimittels zur hemmung der transplantatabstossung bei säugetieren
DK602387D0 (da) Fremgangsmaade til fremstilling af glucosaminer med lav molekylvaegt og anvendelse af saadanne glucosaminer
DE69023957D1 (de) Sulfatierte Polysaccharide, Antikoagulierungs- und Antikomplementärmittel, hergestellt aus Fukanen aus braunen Algen, und Verfahren zu deren Herstellung.
DE69435303D1 (de) Er behandlung von krankheiten bei denen eine cytok
ES2147780T3 (es) Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos.
ATE190623T1 (de) Verwendung von steroiden zur inhibierung von angiogenesis
EP0011651A4 (en) Pharmaceutical preparation containing 3-oxo-2,3-dihydro (1) -benzothiophene-2-spirocyclopropane and this compound for use in the prophylaxis or treatment of caridovascular disorders.
ES2054740T3 (es) Pentadienamidas paf-antagonistas.
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
EP0058397A3 (en) Anticoagulant and the use thereof
ATE81467T1 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
ES2032192T3 (es) Composiciones elastomeras reticulables.
ATE113591T1 (de) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
DE3751362D1 (de) 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva.